Award for stem cell trial that aims to treat severe seizure disorder in children
Murdoch Children’s Research Institute (MCRI) researcher Dr Nicole Van Bergen has been recognised for a project that aims to use stem cell therapy to treat a severe neurological disorder in children.
Dr Van Bergen received the $74,000 Victorian Near-Miss Award for her trial into improving therapeutics for CDKL5 Deficiency Disorder (CDD), a rare genetic condition that causes severe seizures and neurodevelopmental impairment in young children.
“I will use human stem cells to understand the molecular consequences of CDD,” Dr Van Bergen said. This will hopefully lead us to discover new drug candidates and better drug screening to identify new treatments for this disorder.”
The Near-Miss Award aims to support Victorian researchers who narrowly missed out on a 2021 NHMRC Emerging Leader grant.
Dr Van Bergen received the $74,000 Victorian Near-Miss Award for her trial into improving therapeutics for CDKL5 Deficiency Disorder (CDD), a rare genetic condition that causes severe seizures and neurodevelopmental impairment in young children.
“I will use human stem cells to understand the molecular consequences of CDD,” Dr Van Bergen said. This will hopefully lead us to discover new drug candidates and better drug screening to identify new treatments for this disorder.”
The Near-Miss Award aims to support Victorian researchers who narrowly missed out on a 2021 NHMRC Emerging Leader grant.